FRM
SGMT icon

Fox Run Management’s Sagimet Biosciences SGMT Stock Holding History

Fox Run Management’s Portfolio SGMT Stock Details SGMT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$285K Buy
+36,818
New +$250K 0.05% 689

Other funds holding SGMT

Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
FIA
FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return
KAS
Kestra Advisory Services Austin, Texas $31B AUM 28.39% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
MMA
Miracle Mile Advisors Los Angeles, California $8.53B AUM 21.43% 1-Year Est. Return
APG
Abacus Planning Group Columbia, South Carolina $809M AUM 21.71% 1-Year Est. Return
RIA
RPG Investment Advisory Pleasanton, California $973M AUM 39.93% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
NFG
Nations Financial Group Cedar Rapids, Iowa $2.09B AUM 34.27% 1-Year Est. Return

Fox Run Management's SGMT Position: Q2 2026 in Review

Fox Run Management opened a new position in Sagimet Biosciences (SGMT) in Q2 2026: 36,818 shares worth $285K. The stake represents 0.05% of the portfolio and ranks #689 among its holdings.

17 funds tracked by Wall St. Rank hold SGMT as of Q2 2026.

  • Fox Run Management held 36,818 shares of Sagimet Biosciences worth $285K as of Q2 2026.
  • Sagimet Biosciences was a new Fox Run Management position in Q2 2026.
  • Sagimet Biosciences made up 0.05% of Fox Run Management's portfolio in Q2 2026, its #689 holding.
  • 17 funds tracked by Wall St. Rank held Sagimet Biosciences as of Q2 2026.

Based on Fox Run Management's 13F filing for Q2 2026, filed 4 Aug 2026.